VoyForums
[ Show ]
Support VoyForums
[ Shrink ]
VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

[ Login ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1, 2, [3], 4, 5, 6, 7, 8, 9, 10 ]

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 06:17:15 11/30/17 Thu
Author: Merle (qLcQpVFTfZGXxlSQ)
Subject: QAJgjbjTW

About a year kamagra oral jelly en pharmacie The Japanese market is becoming more important to drugmakers as an aging population and a more receptive healthcare market are setting the stage for greater sales. Japan has become increasingly attractive to multinational drugmakers as U.S. sales stagnate and European price cuts actually undermine growth there. AstraZeneca is one of the companies that has been struggling in the face of these obstacles. Much of the attention in Japan will be on generics as an increasingly cost-conscious government works to ratchet up use of cheaper copycats, but the country has also been approving new treatments it has not had before.

[ Next Thread | Previous Thread | Next Message | Previous Message ]

Forum timezone: GMT-8
VF Version: 3.00b, ConfDB:
Before posting please read our privacy policy.
VoyForums(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2019 Voyager Info-Systems. All Rights Reserved.